These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Synthesis of tricyclic carbohydrate-benzene hybrids as selective inhibitors of galectin-1 and galectin-8 N-terminal domains. Wu C; Yong C; Zhong Q; Wang Z; Nilsson UJ; Zhang Y RSC Adv; 2020 May; 10(33):19636-19642. PubMed ID: 35515421 [TBL] [Abstract][Full Text] [Related]
9. Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor development. Dussouy C; Kishor C; Lambert A; Lamoureux C; Blanchard H; Grandjean C Chem Biol Drug Des; 2020 Oct; 96(4):1123-1133. PubMed ID: 32220037 [TBL] [Abstract][Full Text] [Related]
10. Selective Galectin-8N Ligands: The Design and Synthesis of Phthalazinone-d-Galactals. van Klaveren S; Sundin AP; Jakopin Ž; Anderluh M; Leffler H; Nilsson UJ; Tomašič T ChemMedChem; 2022 Mar; 17(6):e202100575. PubMed ID: 34913595 [TBL] [Abstract][Full Text] [Related]
11. Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation. Hassan M; van Klaveren S; Håkansson M; Diehl C; Kovačič R; Baussière F; Sundin AP; Dernovšek J; Walse B; Zetterberg F; Leffler H; Anderluh M; Tomašič T; Jakopin Ž; Nilsson UJ Eur J Med Chem; 2021 Nov; 223():113664. PubMed ID: 34225180 [TBL] [Abstract][Full Text] [Related]
12. Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain. Stowell SR; Arthur CM; Slanina KA; Horton JR; Smith DF; Cummings RD J Biol Chem; 2008 Jul; 283(29):20547-59. PubMed ID: 18456665 [TBL] [Abstract][Full Text] [Related]
13. X-ray structure of a protease-resistant mutant form of human galectin-8 with two carbohydrate recognition domains. Yoshida H; Yamashita S; Teraoka M; Itoh A; Nakakita S; Nishi N; Kamitori S FEBS J; 2012 Oct; 279(20):3937-51. PubMed ID: 22913484 [TBL] [Abstract][Full Text] [Related]